Document Detail


Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
MedLine Citation:
PMID:  17413026     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Beta-amyloid is a key component of Alzheimer's disease (AD) pathology. Researchers in both academic and industry are actively pursuing the development of imaging tracers and techniques to noninvasively measure local levels of beta-amyloid in the Alzheimer's brain. This presentation summarizes recent data and discusses the opportunities and challenges of imaging plaques containing fibrillar beta-amyloid for the early diagnosis and therapeutic monitoring of amyloid targeted therapies. Further, the value and feasibility of measuring the recently described soluble oligomeric form of beta-amyloid as an alternative noninvasive biomarker is also discussed.
Authors:
Michael C Montalto; Gill Farrar; Cristina Tan Hehir
Related Documents :
20833446 - Effects of apoe4 and maternal history of dementia on hippocampal atrophy.
15786476 - Detection of entorhinal layer ii using 7tesla [corrected] magnetic resonance imaging.
12673606 - Accuracy of ct scan measurements of the medial temporal lobe in routine dementia diagno...
20824536 - Hyperhomocysteinemia in alzheimer dementia patients and cognitive decline after 6 month...
472896 - Experimentally induced hypermobility in the lumbar spine. a pathologic and radiologic s...
22223536 - Endoscopic resection of an anterior skull-base schwannoma.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1097     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-04-06     Completed Date:  2007-04-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  239-58     Citation Subset:  IM    
Affiliation:
Molecular Imaging and Diagnostics Advanced Technology Program, Biosciences, GE Global Research Center, Niskayuna, New York, USA. montalto@crd.ge.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / metabolism*,  pathology*
Amyloid beta-Protein / metabolism*,  ultrastructure*
Biological Markers
Blood-Brain Barrier / physiology
Brain / pathology
Brain Chemistry / physiology
Humans
Senile Plaques / metabolism*,  pathology*
Chemical
Reg. No./Substance:
0/Amyloid beta-Protein; 0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imaging-guided microarray: isolating molecular profiles that dissociate Alzheimer's disease from nor...
Next Document:  Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functio...